Revance Therapeutics, Inc. (RVNC) earnings
RVNC earnings moved a median of -5.66% by the close. Quarterly and annual RVNC reports and results, each read against the price at its own news timestamp. Back to the RVNC overview →
12 measured RVNC earnings events.
Where these RVNC earnings landedvs 12 measured RVNC earnings reactions
| Middle 50% of RVNC earnings reactions | -12.53% to +4.33% |
|---|---|
| Median reaction (to close) | -5.66% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 RVNC earnings events with a measured close landed between -12.53% and +4.33%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Revance Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.95% | -12.53% | |
| Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update | Press release | -0.95% | -12.53% | |
| Form 10-Q Revance Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +10.97% | +13.87% | |
| Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update | Press release | +10.97% | +13.87% | |
| Revance to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024 | Press release | -3.40% | -5.33% | |
| Form 10-Q Revance Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -9.88% | -18.02% | |
| Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update | Press release | -9.88% | -18.02% | |
| Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 | Press release | +1.53% | +0.77% | |
| Form 10-K Revance Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.46% | +16.10% | |
| Form 10-Q Revance Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +10.75% | -5.99% | |
| Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update | Press release | +10.75% | -5.99% | |
| Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 | Press release | -2.30% | +1.15% |
Keep exploring
More RVNC: analyst actions → · SEC filings → · RVNC overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PishPosh, Inc. (BABY) | 702 | 0.00% | 48% |
| Insmed Incorporated (INSM) | 701 | -0.08% | 45% |
| AB Corporate Bond ETF (EYEG) | 700 | 0.00% | 44% |
| STEMLINE THERAPEUTICS (STML) | 697 | +0.08% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.